SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

TC Group Cayman Investment Holdings, L.P., et al. – ‘4’ for 5/27/22 re: Ortho Clinical Diagnostics Holdings plc

On:  Tuesday, 5/31/22, at 4:30pm ET   ·   For:  5/27/22   ·   Accession #:  899243-22-20179   ·   File #:  1-39956

Previous ‘4’:  ‘4’ on 12/9/21 for 12/8/21   ·   Next & Latest:  ‘4’ on 5/10/23 for 5/8/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/31/22  TC Gp Cayman Inv Holdings, L.P.   4                      1:19K  Ortho Clinical Diagnostics H… plc Donnelley Fin’l S… 06/FA
          Carlyle Group Inc.
          Carlyle Holdings II GP L.L.C.
          Carlyle Holdings II L.L.C.
          TC Group VI Cayman, L.P.
          CG Subsidiary Holdings L.L.C.
          TC Group Cayman Investment Holdings Sub L.P.
          TC Group VI Cayman, L.L.C.
          Carlyle Partners VI Cayman Holdings, L.P.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      4K


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Form 4 Submission
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Carlyle Group Inc.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
Ortho Clinical Diagnostics Holdings plc [ OCDX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
5/27/22
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares, $0.00001 par value 5/27/22D 118,106,000D (1)0ISee footnotes (2) (3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Carlyle Group Inc.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Holdings II GP L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Holdings II L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
CG Subsidiary Holdings L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE. N.W., SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group Cayman Investment Holdings, L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group Cayman Investment Holdings Sub L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group VI Cayman, L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group VI Cayman, L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Partners VI Cayman Holdings, L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
Explanation of Responses:
(1)  Pursuant to the Business Combination Agreement, dated December 22, 2021 (the "BCA"), by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). At the Effective Time, each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash.
(2)  Reflects ordinary shares held of record by Carlyle Partners VI Cayman Holdings, L.P. (the "Carlyle Investor"). The Carlyle Group Inc., a publicly traded company listed on Nasdaq, is the sole member of Carlyle Holdings II GP L.L.C., which is the managing member of Carlyle Holdings II L.L.C., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the general partner of TC Group Cayman Investment Holdings, L.P., which is the general partner of TC Group Cayman Investment Holdings Sub L.P., which is the sole member of TC Group VI Cayman, L.L.C., which is the general partner of TC Group VI Cayman, L.P., which is the general partner of the Carlyle Investor.
(3)  Voting and investment determinations with respect to the ordinary shares held of record by the Carlyle Investor are made by an investment committee of TC Group VI Cayman, L.P. Accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by the Carlyle Investor. Each of them disclaims beneficial ownership of such securities.
Remarks:
The Carlyle Group Inc., By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Managing Director and Chief Financial Officer 5/31/22
Carlyle Holdings II GP L.L.C., By: The Carlyle Group Inc., its sole member, By: /s/ Anne Frederick, Attorney in fact for Curtis L. Buser, Managing Director and Chief Financial Officer 5/31/22
Carlyle Holdings II L.L.C., By /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Managing Director 5/31/22
CG Subsidiary Holdings L.L.C., By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Managing Director 5/31/22
TC Group Cayman Investment Holdings, L.P., By: CG Subsidiary Holdings L.L.C., its general partner, By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Managing Director 5/31/22
TC Group Cayman Investment Holdings Sub L.P., By: TC Group Cayman Investment Holdings, L.P., its general partner, By: CG Subsidiary Holdings L.L.C., its general partner, By: /s/ Anne Frederick, Attorney in fact for Curtis L. Buser, Managing Director 5/31/22
TC Group VI Cayman, L.L.C., By: /s/ Jeremy W. Anderson, Authorized Person 5/31/22
TC Group VI Cayman, L.P., By: /s/ Jeremy W. Anderson, Authorized Person 5/31/22
Carlyle Partners VI Cayman Holdings, L.P., By: /s/ Jeremy W. Anderson, Authorized Person 5/31/22
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    D    Disposition to the Issuer of Issuer equity securities pursuant to Rule 16b-3(e).

↑Top
Filing Submission 0000899243-22-020179   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 9, 3:07:46.2am ET